#Chronic_Inflammatory_Disease - Biweekly newsletter of the International Cytokine & Interferon Society

Judi Allen, PhD, tapped to lead new MRC-UK Research Centre to study the Immunology of the Exposome

August 2, 2025

A £50M MRC Centre of Research Excellence (CoRE) will bring together the Universities of Manchester & Oxford to study how environmental exposures cause chronic inflammatory disease. The CoRE will be Directed by Judi Allen (Manchester) & co-Directed by Fiona Powrie (Oxford). The Centre unites immunologists based at the Lydia Becker [READ MORE]

Going for Gold: The Olympic Spirit of Cytokine Science

March 1, 2026

The Winter Olympics brought a much-needed mental break during a February- the middle of Northwestern’s Winter Quarter, a respite from undergraduate teaching, grant writing, and the pandemonium of ongoing political noise. The beauty of the snowy Milan-Cortino mountains of was a perfect backdrop to the gathering of outstanding athletes from [READ MORE]

Photo of Anna Dittrich on a cold, windy beach

From Düsseldorf to Tokyo — and Back to IL-6: Meet Anna Dittrich

March 1, 2026

I´m a biologist by training and currently work as a senior researcher at the Otto von Guericke University Magdeburg, Germany. My research focuses on understanding how intracellular cytokine-induced signaling robustly encodes and transmits information, with a special focus on my favorite cytokine IL-6. Please tell us your name, degree, where [READ MORE]

Concentrations of Pro-inflammatory and Anti-inflammatory Cytokines and Metallopeptidases in the Serum During the Treatment of Pain Caused by Bulging of the Intervertebral Disc in the Lumbar Spine

March 1, 2026

Concentrations of Pro-inflammatory and Anti-inflammatory Cytokines and Metallopeptidases in the Serum During the Treatment of Pain Caused by Bulging of the Intervertebral Disc in the Lumbar Spine ClinicalTrials.gov ID NCT06545812 Sponsor: Josip Juraj Strossmayer, University of Osijek Information provided: by Karla Rožac, Josip Juraj Strossmayer, University of Osijek (Responsible Party) [READ MORE]

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

March 1, 2026

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia ClinicalTrials.gov ID NCT05600920 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Information provided by: National Institutes of Health Clinical Center (CC) (National Institute of Allergy and Infectious Diseases (NIAID)) (Responsible Party) Last Update [READ MORE]

Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)

March 1, 2026

Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23) ClinicalTrials.gov ID NCT06792487 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Information provided by: Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Responsible Party) Last Update Posted: 2025-01-24 Brief Summary Psoriasis is an immune-mediated inflammatory skin disease characterized by the presence [READ MORE]

Share this: